Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital... Show more
Marsh & McLennan Companies (MRSH) maintains a dominant position in the global insurance brokerage and consulting industry, operating through its Risk and Insurance Services (Marsh, Guy Carpenter) and Consulting (Mercer, Oliver Wyman) segments. The company serves clients across risk management, reinsurance broking, health, wealth, career solutions, and management consulting, generating roughly half its revenue outside the U.S. This diversified, fee-based model provides resilience across economic cycles.
Competitive advantages include market-leading scale, deep expertise in emerging risks like cyber and climate, and a robust M&A (mergers and acquisitions) track record—completing nearly 300 deals in 2024 alone. The recent $7.75 billion McGriff acquisition expands middle-market capabilities, expected to be accretive to adjusted EPS starting 2026. Innovation in AI, data analytics, and the new Business and Client Services unit further strengthens its edge against peers like Aon and Willis Towers Watson.
The Q1 2026 earnings release on April 16 will offer insights into organic growth, Thrive program execution, and McGriff integration, with analysts forecasting adjusted EPS of $3.22, up 5.2% year-over-year. Full-year 2026 consensus projects revenue around $28 billion (4-5% growth) and EPS near $10.34, reflecting 6-9% expansion.
Ongoing tuck-in acquisitions, such as Mercer's AltamarCAM deal for private markets, signal continued inorganic growth in high-margin areas. Analyst sentiment remains balanced, with 22-27 firms issuing a "Hold/Outperform" consensus; recent actions include Barclays maintaining Overweight at $206 and Keefe Bruyette trimming to $200 (Market Perform). Price target revisions trend slightly lower amid softer P&C outlook but imply 16-20% upside potential.
These catalysts could shift investor sentiment if they affirm mid-single-digit organic revenue growth and margin expansion.
MRSH's trajectory is shaped by evolving insurance industry dynamics, including hardening rates from catastrophe losses, social inflation, and cyber threats, which drive demand for brokerage services. Supply chain disruptions and geopolitical tensions further elevate risk advisory needs.
Macro factors like interest rates influence insurer investment income and client borrowing, indirectly affecting broking volumes. Inflation supports higher insured values but pressures consulting clients amid economic uncertainty. A slowing GDP growth environment (projected 2.5-3% U.S. real GDP) may temper consulting demand, while steady global P&C premium growth (~5% CAGR) provides tailwinds. Regulatory shifts in data privacy and ESG (environmental, social, governance) also play a role, with MRSH well-positioned via its analytics platforms.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. Designed to spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments, it leverages advanced machine learning models trained on historical price action, volume, and technical indicators. The tool includes searchable prediction categories, historical performance context for similar patterns, and alert functionality to notify users of potential shifts. For investors tracking MRSH amid volatile markets, it offers data-driven insights to complement traditional analysis. Explore the Trend Prediction Engine today to enhance your trading decisions.
Analysts forecast 2026 revenue growth of 4-5% to ~$28 billion and EPS expansion to $10.34, supported by Thrive efficiencies, AI investments, and geographic expansion in Asia-Pacific and Latin America. Margin sustainability hinges on 20-40 basis points annual improvement, targeting high-single to low-double-digit EPS growth.
Long-term drivers include market expansion via accretive M&A, cost evolution through automation, and technology transitions like AI for risk modeling. Competitive threats from digital disruptors loom, but MRSH's scale and client wallet share gains mitigate them. Regulatory developments in cyber and climate risk, alongside capital priorities like share repurchases and debt reduction (targeting low-2.0x leverage), will shape sentiment. Consensus expects moderate growth mirroring industry peers, with resilience in a fragmented landscape.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KMLI | 10.87 | 0.16 | +1.45% |
| KraneShares 2x Long MELI Daily ETF | |||
| JHID | 42.59 | N/A | N/A |
| JHancock International High Dividend ETF | |||
| HDV | 133.46 | -0.48 | -0.36% |
| iShares Core High Dividend ETF | |||
| EPOL | 40.35 | -0.29 | -0.71% |
| iShares MSCI Poland ETF | |||
| TSLR | 22.64 | -0.93 | -3.95% |
| GraniteShares 2x Long TSLA Daily ETF | |||
A.I.dvisor indicates that over the last year, MRSH has been closely correlated with AON. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if MRSH jumps, then AON could also see price increases.
| Ticker / NAME | Correlation To MRSH | 1D Price Change % | ||
|---|---|---|---|---|
| MRSH | 100% | -0.69% | ||
| AON - MRSH | 74% Closely correlated | +0.05% | ||
| AJG - MRSH | 72% Closely correlated | +0.66% | ||
| BRO - MRSH | 68% Closely correlated | +0.09% | ||
| WTW - MRSH | 65% Loosely correlated | -0.36% | ||
| ERIE - MRSH | 43% Loosely correlated | +3.53% | ||
More | ||||
| Ticker / NAME | Correlation To MRSH | 1D Price Change % |
|---|---|---|
| MRSH | 100% | -0.69% |
| MRSH (5 stocks) | 85% Closely correlated | -0.05% |
| Insurance Brokers/Services (22 stocks) | 80% Closely correlated | +1.35% |
| Insurance (240 stocks) | 60% Loosely correlated | -0.25% |
The Moving Average Convergence Divergence (MACD) for MRSH turned positive on March 30, 2026. Looking at past instances where MRSH's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MRSH's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on April 15, 2026. You may want to consider a long position or call options on MRSH as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRSH advanced for three days, in of 367 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 290 cases where MRSH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where MRSH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
MRSH moved below its 50-day moving average on April 20, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRSH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MRSH broke above its upper Bollinger Band on April 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MRSH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.774) is normal, around the industry mean (6.270). P/E Ratio (21.824) is within average values for comparable stocks, (28.150). Projected Growth (PEG Ratio) (1.704) is also within normal values, averaging (1.643). Dividend Yield (0.021) settles around the average of (0.018) among similar stocks. P/S Ratio (3.120) is also within normal values, averaging (2.797).